The All Ordinaries Index (ASX: XAO) has slumped 1.6% in 2026, but this ASX All Ords healthcare share has taken a much bigger hit.
The beaten down stock in question is Oneview Healthcare (ASX: ONE).
In early afternoon trade on Wednesday, OneView Healthcare shares are down 3.0%, trading for 16 cents apiece.
This sees the ASX All Ords healthcare share down a painful 60.0% year to date.
Looking ahead, however, Securities Vault's Nathan Lodge believes the company, which provides digital tools for patients, families and caregivers, could be poised to rebound (courtesy of The Bull).
OneView is currently partnered with healthcare systems in the United States, Australia, Ireland, the Middle East and Asia, helping to unify the care experience in more than 80 hospitals.
Should you buy the ASX All Ords healthcare share today?
"Its care experience platform integrates patient engagement tools into hospital systems," said Lodge, who has a buy recommendation on the ASX All Ords healthcare share.
"The company's offering should generate demand," he added. "Potential upside exits following positive momentum."
According to Lodge:
The investment thesis hinges on hospital digitisation and patient experience mandates, particularly in the US, where funding tailwinds remain supportive.
As for the second reason you might want to buy OneView shares today, Lodge said, "As deployments scale up, Oneview's recurring revenue model should drive operating leverage."
Summing up his bullish outlook on the beaten down stock, Lodge concluded, "Importantly, the company has already secured major hospital clients, reducing execution risk compared to earlier stage peers."
What's the latest from OneView?
OneView Healthcare reported its March quarter results on 27 April.
The ASX All Ords healthcare share closed up 2.9% on the day after reporting a $9 million quarter-on-quarter increase in its cash balance to $17.1 million. That was spurred by a successful $19 million capital raising during the quarter.
"The successful completion of the recent capital raise in extremely challenging market conditions represents a strong endorsement of Oneview's strategy and execution," OneView Healthcare CEO James Fitter said.
Looking ahead, Fitter added:
The first quarter of the year has been a busy period for the business, with continued engagement across our sales channels and progress that supports our objectives for 2026…
With a strengthened balance sheet, continued deployment activity across new and existing customers, and growing demand for digitally supported bedside experiences, the company is well positioned to maintain momentum as we progress through the year.
The post 3 reasons this beaten down ASX All Ords healthcare share could come roaring back appeared first on The Motley Fool Australia.
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026